Therapeutic Potential Unveiled
The conversation delves into the groundbreaking work surrounding the therapeutic potential of MDMA, emphasizing the importance of proper training for practitioners involved in clinical trials. Questions arise regarding the FDA's stance on who can provide this treatment, highlighting the need for licensed professionals and the potential roles of psychiatrists and psychologists. Safety considerations, particularly concerning cardiac issues, underscore the necessity of having a physician present during administration.In this clip
From this podcast
Huberman Lab
Dr. Robin Carhart-Harris: The Science of Psychedelics for Mental Health | Huberman Lab Podcast
Related Questions